Randomized sham-controlled trial of the 6-month swallowable gas-filled intragastric balloon system for weight loss

Efficacy and Safety of Endoscopic Sleeve Gastroplasty: A Systematic Review and Meta-Analysis

“…10,11 This is dissimilar to other endoscopic bariatric therapies, including intragastric balloons and aspiration therapy, in which level 1 evidence exists. [12][13][14][15] Therefore, there is a need to synthesize the available literature pertaining to ESG to arm the clinician with the data required to facilitate a data driven discussion with patients interested in the procedure. The aim of the systematic review and meta-analysis was to evaluate the efficacy of ESG for significant and sustained weight loss and define the risk of severe adverse events.…”

Gastric space-occupying devices for management of obesity and metabolic disease

“…The responder rate in the treatment group was 66%. As to complications, there were one deflation and one gastric ulcer, and the rate of serious adverse events was as low as 0.3% [58].…”

Short-term Outcomes of Intragastric Balloon Placement for Obesity Treatment

“…1,2 현재 시행되고 있는 내시경 치료는 위풍선(intragastric balloon) 삽입술, 위성형술(gastroplasty), 흡입 치료(aspiration therapy) 등이 있다. 3 이 중 가장 먼저 시 작된 방법은 위풍선 삽입술로, 4 현재 미국이나 유럽에서 활발하 게 시행되고 있고 단기간의 체중 감량 효과가 입증되었다. [4][5][6][7] 최근 국내에서도 내시경을 통한 위풍선 삽입술의 시행 횟수 가 점차 증가하고 있으나 8,9 위풍선을 제거한 후에도 감소된 체 중이 유지되는지는 명확하지 않고, 관련된 연구 역시 부족하 다.…”